Back to results
US 2025/0049595 A1Published application
Zotarolimus-rosuvastatin eluting biodegradable stent
OwnerDev GADHIAinventor
Life of this patent
Estimating the term…
Abstract
A drug-eluting stent for insertion in a blood vessel includes a tubular mesh structure composed of a magnesium alloy and a poly-L-lactide layer that is micro arc oxidized disposed over the tubular mesh structure. The biodegradable drug-eluting stent further includes Zotarolimus and Rosuvastatin integrated into the poly-L-lactide layer to provide controlled and sustained drug release. Advantageously, wherein the drug-eluting stent is configured to be deployed in the blood vessel to provide drug delivery to a target site.
Claims14
A drug-eluting stent for insertion in a blood vessel, comprising:
- a) a tubular mesh structure composed of a magnesium alloy;
- b) a poly-L-lactide layer disposed over the tubular mesh structure;
- and
- c) Zotarolimus and Rosuvastatin or pharmaceutically derivatives thereof integrated into the poly-L-lactide layer to provide controlled and sustained drug release, wherein the drug-eluting stent is configured to be deployed in the blood vessel to provide drug delivery to a target site.
1 more element
Dependencies are inferred from the claim text.